Cargando…

Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus

Inositol, an emerging novel therapy for the treatment of gestational diabetes mellitus (GDM), is a cyclic polyol that has insulin-like effects and plays an important role in glucose homeostasis. The conventional treatment of GDM with insulin and oral antihyperglycemic drugs usually comes with side e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahir, Faryal, Majid, Zainab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823013/
https://www.ncbi.nlm.nih.gov/pubmed/31720147
http://dx.doi.org/10.7759/cureus.5671
_version_ 1783464457472573440
author Tahir, Faryal
Majid, Zainab
author_facet Tahir, Faryal
Majid, Zainab
author_sort Tahir, Faryal
collection PubMed
description Inositol, an emerging novel therapy for the treatment of gestational diabetes mellitus (GDM), is a cyclic polyol that has insulin-like effects and plays an important role in glucose homeostasis. The conventional treatment of GDM with insulin and oral antihyperglycemic drugs usually comes with side effects, paving the way for and shedding spotlight on clinical trials involving inositol. This review analyzed a host of recent trials that involved inositol supplementation for preventing GDM and their positive outcomes in reducing the rate of GDM among obese and overweight pregnant women, as well as women with polycystic ovarian syndrome (PCOS) or a family history of type 2 diabetes mellitus.
format Online
Article
Text
id pubmed-6823013
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-68230132019-11-12 Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus Tahir, Faryal Majid, Zainab Cureus Family/General Practice Inositol, an emerging novel therapy for the treatment of gestational diabetes mellitus (GDM), is a cyclic polyol that has insulin-like effects and plays an important role in glucose homeostasis. The conventional treatment of GDM with insulin and oral antihyperglycemic drugs usually comes with side effects, paving the way for and shedding spotlight on clinical trials involving inositol. This review analyzed a host of recent trials that involved inositol supplementation for preventing GDM and their positive outcomes in reducing the rate of GDM among obese and overweight pregnant women, as well as women with polycystic ovarian syndrome (PCOS) or a family history of type 2 diabetes mellitus. Cureus 2019-09-16 /pmc/articles/PMC6823013/ /pubmed/31720147 http://dx.doi.org/10.7759/cureus.5671 Text en Copyright © 2019, Tahir et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Tahir, Faryal
Majid, Zainab
Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus
title Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus
title_full Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus
title_fullStr Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus
title_full_unstemmed Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus
title_short Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus
title_sort inositol supplementation in the prevention of gestational diabetes mellitus
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823013/
https://www.ncbi.nlm.nih.gov/pubmed/31720147
http://dx.doi.org/10.7759/cureus.5671
work_keys_str_mv AT tahirfaryal inositolsupplementationinthepreventionofgestationaldiabetesmellitus
AT majidzainab inositolsupplementationinthepreventionofgestationaldiabetesmellitus